ORIC — ORIC PHARMACEUTICALS INC

Ownership history in STEMPOINT CAPITAL LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in ORIC PHARMACEUTICALS INC (ORIC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.65% (2025 Q2)
Avg. % of fund
0.53%
First filed
2025 Q2
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 166,461 -34,324 -17.1% 0.40% $2.0M $12.00
2025 Q2 INITIATED 200,785 — — 0.65% $2.0M $10.15
% of Fund (quarterly)    ORIC price (monthly, adj. close)

Other funds also holding ORIC

As of 2025 Q4 — sorted by position size

Column Group LLC 3Y 34.98% PFIZER INC 18.6% SR ONE CAPITAL MANAGEMENT, LP 3Y 5.34% EcoR1 Capital, LLC 3Y 7Y 2.5% VR Adviser, LLC 3Y 2.29% Euclidean Capital LLC 3Y 2.19% First Turn Management, LLC 1.88% NEA Management Company, LLC 3Y 7Y 1.72% MPM BioImpact LLC 3Y 1.68% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.59%
← Back to STEMPOINT CAPITAL LP Holdings